Effect of rosiglitazone on inflammatory cytokines and oxidative stress after intensive insulin therapy in patients with newly diagnosed type 2 diabetes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of rosiglitazone on inflammatory cytokines and oxidative stress after intensive insulin therapy in patients with newly diagnosed type 2 diabetes
Authors
Keywords
-
Journal
Diabetology & Metabolic Syndrome
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-03
DOI
10.1186/s13098-019-0432-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline
- (2019) Derek LeRoith et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mechanism of Generation of Oxidative Stress and Pathophysiology of Type 2 Diabetes Mellitus: How Are They Interlinked?
- (2017) Kanwal Rehman et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome
- (2017) Jiao Wang et al. MEDICINE
- The role of oxidative stress on the pathophysiology of metabolic syndrome
- (2017) Fabiane Valentini Francisqueti et al. Revista da Associacao Medica Brasileira
- Latent Inflammation and Insulin Resistance in Adipose Tissue
- (2017) I. S. Stafeev et al. International Journal of Endocrinology
- The Impact of Pharmacotherapy of Type 2 Diabetes Mellitus on IL-1�, IL-6 and IL-10 Secretion
- (2016) Magdalena Borowska et al. PHARMACOLOGY
- Effects of Metformin on Tissue Oxidative and Dicarbonyl Stress in Transgenic Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein
- (2016) Hana Malínská et al. PLoS One
- Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial
- (2015) H. Florez et al. DIABETES OBESITY & METABOLISM
- Correlation of the plasma levels of soluble RAGE and endogenous secretory RAGE with oxidative stress in pre-diabetic patients
- (2015) Minglian Huang et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Rodney A. Hayward et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people
- (2015) Anoop Dinesh Shah et al. Lancet Diabetes & Endocrinology
- Physiologic Versus Diabetogenic Effects of Interleukin-1: A Question of Weight
- (2014) Hugo Besedovsky et al. CURRENT PHARMACEUTICAL DESIGN
- Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?
- (2014) Philip Home et al. DIABETES CARE
- Comparison of Effects of Gliclazide, Metformin and Pioglitazone Monotherapies on Glycemic Control and Cardiovascular Risk Factors in Patients with Newly Diagnosed Uncontrolled Type 2 Diabetes Mellitus
- (2014) C. Erem et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Effect of Metformin on Methylglyoxal Metabolism in Patients with Type 2 Diabetes
- (2014) Z. Kender et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease
- (2014) Nathalie Esser et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation
- (2014) Martin Pal et al. IMMUNOLOGY AND CELL BIOLOGY
- Insulin alleviates the inflammatory response and oxidative stress injury in cerebral tissues in septic rats
- (2014) Qiyi Chen et al. Journal of Inflammation-London
- Rosiglitazone Causes Cardiotoxicity via Peroxisome Proliferator-Activated Receptor γ-Independent Mitochondrial Oxidative Stress in Mouse Hearts
- (2014) Huamei He et al. TOXICOLOGICAL SCIENCES
- Rosiglitazone Regulates Anti-Inflammation and Growth Inhibition via PTEN
- (2014) Chiou-Feng Lin et al. Biomed Research International
- Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study
- (2013) G. Lowe et al. DIABETES
- Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
- (2013) Francesco Paneni et al. EUROPEAN HEART JOURNAL
- Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis
- (2013) S. Kaptoge et al. EUROPEAN HEART JOURNAL
- Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents Metformin and its clinical use: new insights for an old drug in clinical practice
- (2012) Arrigo F.G. Cicero et al. Archives of Medical Science
- Effects of Rosiglitazone with Insulin Combination Therapy on Oxidative Stress and Lipid Profile in Left Ventricular Muscles of Diabetic Rats
- (2012) Servet Kavak et al. Experimental Diabetes Research
- Effects of Rosiglitazone/Metformin Fixed-Dose Combination Therapy and Metformin Monotherapy on Serum Vaspin, Adiponectin and IL-6 Levels in Drug-Naïve Patients with Type 2 Diabetes
- (2010) N. P. E. Kadoglou et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- The Association Between C-Reactive Protein Levels and Insulin Therapy in Obese vs Nonobese Veterans With Type 2 Diabetes Mellitus
- (2010) Sameed Ahmed M. Khatana et al. Journal of Clinical Hypertension
- Pleiotropic Action of Short-Term Metformin and Fenofibrate Treatment, Combined With Lifestyle Intervention, in Type 2 Diabetic Patients With Mixed Dyslipidemia
- (2009) M. Pruski et al. DIABETES CARE
- Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain: Observations from A Diabetes Outcome Progression Trial (ADOPT)
- (2009) S. E. Kahn et al. DIABETES CARE
- Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes
- (2009) Aruna D. Pradhan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started